Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +35.77%
#2 Siren Siren +30.76%
#3 Purr Purr +29.34%
#4 OriginTrail OriginTrail +23.32%
#5 UnifAI Network UnifAI Network +16.08%
#6 龙虾 (Lobster) 龙虾 (Lobster) +14.51%
#7 Pendle Pendle +14.37%
#8 ApeX ApeX +14.28%
#9 Morpho Morpho +13.97%
#10 DigiByte DigiByte +13.84%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Peringkat dalam Saham #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Harga Saham
$50.82
Terakhir disinkronkan: 2026-08-11
Kapitalisasi Pasar
$102.09M
Perubahan (1 hari)
1.90%
Perubahan (1 tahun)
-
Negara
US
Perdagangan Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Kategori

Healthcare
Riwayat dividen untuk Hemab Therapeutics Holdings, Inc. Common Stock (COAG)
Saham Hemab Therapeutics Holdings, Inc. Common Stock (simbol: COAG) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk Hemab Therapeutics Holdings, Inc. Common Stock (COAG) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH